Log In
Print this Print this

Capesaris (GTx-758)

  Manage Alerts
Collapse Summary General Information
Company GTx Inc.
DescriptionOral selective estrogen receptor alpha agonist
Molecular Target Estrogen receptor alpha
Mechanism of ActionEstrogen receptor alpha agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationProstate cancer
Indication DetailsTreat advanced prostate cancer; Treat metastatic castration-resistant prostate cancer (CRPC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today